Scan to download
Home Flash
Depth
Calendar
Data
Find
BTC $70,751.99 -3.93%
ETH $1,982.43 -1.07%
BNB $688.76 -2.74%
XRP $1.29 -3.48%
SOL $80.31 -2.25%
TRX $0.3436 -1.87%
DOGE $0.0995 -0.57%
ADA $0.2284 -2.43%
BCH $289.43 -4.11%
LINK $8.94 -1.76%
HYPE $72.86 +2.03%
AAVE $79.56 -2.85%
SUI $0.8662 -2.71%
XLM $0.2422 -5.23%
ZEC $546.79 -1.24%
BTC $70,751.99 -3.93%
ETH $1,982.43 -1.07%
BNB $688.76 -2.74%
XRP $1.29 -3.48%
SOL $80.31 -2.25%
TRX $0.3436 -1.87%
DOGE $0.0995 -0.57%
ADA $0.2284 -2.43%
BCH $289.43 -4.11%
LINK $8.94 -1.76%
HYPE $72.86 +2.03%
AAVE $79.56 -2.85%
SUI $0.8662 -2.71%
XLM $0.2422 -5.23%
ZEC $546.79 -1.24%
Home
Article
Flash
Specials
Columns
Knowledge Base
Calendar
Markets
Charts
Activity
Tools

Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc

2025-12-02 22:26:45
Collection

According to market news, Nasdaq-listed biotech company Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc.

Previously, it was reported that Hyperliquid Strategies submitted an S-1 filing to raise up to $1 billion, which may be used to purchase HYPE tokens.

source Source
warnning Risk warning
Related tags
Sonnet Biotherapeutics Hyperliquid Strategies Inc
Related reading
Data: HYPE Financial Company Hyperliquid Strategies Inc recently increased its holdings by 220,000 HYPE, worth approximately 8.58 million USD
2026-04-09 17:18
Pavel Durov: The native token of TON has been renamed to Gram, while the blockchain name remains unchanged
2026-06-01 23:53
Vitalik: It is worth considering and trying to build index-tracking assets based on options rather than debt
2026-06-01 23:30
Related tags
Sonnet Biotherapeutics Hyperliquid Strategies Inc
Copyright © 2023
About Us
Media Kit
Apply column
Privacy Policy
Risk Warning
Hiring
Qiong ICP No. 2021009392
Qiong ICP No. 2021009392
app_icon
ChainCatcher Building the Web3 world with innovations.